Protalix BioTherapeutics Inc

An Analysis of Protalix BioTherapeutics Inc (PLX)’s Potential Price Growth
Anna Perez
Protalix BioTherapeutics Inc’s recent filing unveils that its Director Schwartz Aharon acquired Company’s shares for reported $0.21 million on Jun ...





